Marcus Brennecke

Marcus Brennecke

Director/Board Member at RECIPHARM AB (PUBL)

Net worth: 818 M $ as of 2026-05-30

65 year
Health Technology
Consumer Services
Finance

Profile

Marcus Brennecke is currently Director at Recipharm AB and Cerba HealthCare SAS. Mr. Brennecke is Institutional Partner at EQT Partners GmbH since 2005.
Mr. Brennecke is Member-Supervisory Board at CBR Service GmbH since 2015.
Former positions include Director at ISS World Services A and Duni AB. Mr. Brennecke was Director at Galderma Group AG from 2024 to 2026.
Mr. Brennecke was Member-Supervisory Board at Springer Nature Deutschland GmbH and Ottobock SE & Co. KGaA. Education includes undergraduate studies at the University of St. Gallen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
1.92%
2026-04-15 23,653,246 ( 1.92% ) 818 M $ 2026-05-30

Marcus Brennecke active positions

CompaniesPositionStart
RECIPHARM AB (PUBL) Director/Board Member -
Private Equity Investor 2004-12-31
Director/Board Member 2014-12-31
Director/Board Member -
Founder 2019-12-31

Former positions of Marcus Brennecke

CompaniesPositionEnd
OTTOBOCK SE & CO. KGAA Director/Board Member -
Director/Board Member -
Director/Board Member -
DUNI AB Director/Board Member -
See the detail of Marcus Brennecke's experience

Training of Marcus Brennecke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Commercial Services

Consumer Durables

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

Consumer Non-Durables

Health Services

Finance

  1. Stock Market
  2. Insiders
  3. Marcus Brennecke